Measure biomolecular interactions in real time—without tying up your budget. Lease the biolayer interferometer that fits your workflow.
BLI is an optical biosensing technique that detects molecular interactions in real time, without the need for labels. It's widely used to measure binding affinity, kinetics, and concentration in antibody discovery, vaccine development, and protein-protein interaction studies. The technique supports rapid screening and characterization workflows while minimizing sample consumption and assay complexity.
BLI has become a powerful alternative to traditional biosensing techniques like SPR—enabling high-throughput, label-free analysis of molecular binding. But top-tier BLI systems come at a high price, often limiting access for smaller labs, early-stage biotechs, or CROs.
Leasing removes those barriers, giving you immediate access to the latest BLI platforms without large capital outlays. It’s ideal for teams advancing antibody discovery, optimizing binding kinetics, or validating biotherapeutic interactions. Leasing also offers room to scale as project scope and throughput requirements change.
Leasing is especially valuable when:
Whether you’re measuring affinity constants or confirming specificity, leasing a BLI helps you move faster and smarter—without locking up your budget.
Ideal for early-stage or venture-backed teams—and a smart option for any lab looking to preserve equity while scaling.
No inventory limitations. You choose the system that fits your workflow—we handle the financing.
2–5 year terms that support your budget, equipment lifecycle, and scaling timeline.
Get approved in days—not weeks—with no collateral, IP pledges, or debt covenants required.
Equipment sourcing, vendor coordination, and lease logistics are streamlined to reduce your team’s internal workload.
Our vendor relationships help resolve issues quickly—so you stay productive and hit key milestones.
Treat lease payments as operating expenses, not debt. This simplifies accounting and preserves flexibility.
Convert owned equipment into working capital. Keep it off your balance sheet and treat payments as operating expenses.
Already have a quote or PO? Just let us know the equipment you want to lease—we’ll take it from there.
Our in-house underwriting team reviews your financials fast—no outsourcing, no red tape—so you get a decision in days, not weeks.
We handle the logistics and coordinate with the vendor so you can get to work—no upfront capital required.
Don’t let capital constraints limit your lab’s biosensing capabilities. Our leasing program is designed to remove friction from equipment procurement so you can stay focused on producing accurate, reliable results.